---
figid: PMC7796410__molecules-26-00132-g002
figtitle: Peptide-Based Nanomaterials for Tumor Immunotherapy
organisms:
- NA
pmcid: PMC7796410
filename: molecules-26-00132-g002.jpg
figlink: /pmc/articles/PMC7796410/figure/molecules-26-00132-f002/
number: F2
caption: 'Peptide-functionalized nanomaterials for immune checkpoint blockade. (A)
  iRGD-modified nanoparticles, DOX@MSN-SS-iRGD&1MT, simultaneously delivered chemotherapeutic
  agent DOX and immune checkpoint inhibitor 1MT into orthotopic glioma, which exerted
  a superior antitumor effect in vivo. Reproduced from Reference [] with permission.
  Copyright: 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (B) Peptide TAT-NLS
  with cell-penetration and nuclear-transport functions mediated CRISPR–Cas9 (gene
  editing technology, which modifies specific DNA of targeted genes) plasmid delivery
  for β-catenin knockout and blocked the PD-1/PD-L1 pathway to improve the antitumor
  immune response of immune cells. Reproduced from Reference [] with permission. Copyright:
  2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'
papertitle: Peptide-Based Nanomaterials for Tumor Immunotherapy.
reftext: Lingyun Li, et al. Molecules. 2021 Jan;26(1):132.
year: '2021'
doi: 10.3390/molecules26010132
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI
keywords: peptide-based nanomaterials | immune checkpoint blockade | peptide self-assembly
  | peptide screening
automl_pathway: 0.5127501
figid_alias: PMC7796410__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC7796410__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7796410__molecules-26-00132-g002.html
  '@type': Dataset
  description: 'Peptide-functionalized nanomaterials for immune checkpoint blockade.
    (A) iRGD-modified nanoparticles, DOX@MSN-SS-iRGD&1MT, simultaneously delivered
    chemotherapeutic agent DOX and immune checkpoint inhibitor 1MT into orthotopic
    glioma, which exerted a superior antitumor effect in vivo. Reproduced from Reference
    [] with permission. Copyright: 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
    (B) Peptide TAT-NLS with cell-penetration and nuclear-transport functions mediated
    CRISPR–Cas9 (gene editing technology, which modifies specific DNA of targeted
    genes) plasmid delivery for β-catenin knockout and blocked the PD-1/PD-L1 pathway
    to improve the antitumor immune response of immune cells. Reproduced from Reference
    [] with permission. Copyright: 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - bod
  - msn
  - pan
  - Rpn3
  - Dox-3
  - Decay
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - gem
  - geminin
  - dally
  - BCL2L11
  - MSN
  - PDGFB
  - HNF4A
  - CD44
  - CD274
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GEM
  - GMNN
---
